22 results
DEFC14A
LAB
Standard BioTools Inc.
21 May 24
Proxy in contested solicitation
5:15pm
available under Delaware law.”
Opposition Statement of the Company’s Board of Directors
The Board believes that the classified board structure, consisting … the existing classified board structure. The Board is committed to strong corporate governance policies and believes that its current classified Board structure
PRER14A
LAB
Standard BioTools Inc.
20 May 24
Preliminary revised proxy
6:03am
that the classified board structure, consisting of three classes of directors with each class being elected for a three-year term, provides the Company … strongly supports maintaining the existing classified board structure. The Board is committed to strong corporate governance policies and believes that its
PREC14A
LAB
Standard BioTools Inc.
10 May 24
Preliminary proxy with contested solicitation
5:16pm
.”
Opposition Statement of the Company’s Board of Directors
The Board believes that the classified board structure, consisting of three classes of directors … other color proxy card you may receive, even to vote against Proposal 5.
The Board strongly supports maintaining the existing classified board structure
8-K
LAB
Standard BioTools Inc.
18 Mar 24
Standard BioTools Announces Exchange of All Outstanding Series B Convertible Preferred Stock for Common Stock
9:14am
not assigned to classes within the Company’s classified Board structure. On March 18, 2024, upon the effectiveness of the Certificates of Elimination
8-K/A
EX-99.2
ojnap
19 Jan 24
Financial Statements and Exhibits
4:33pm
424B3
3yi9vnm
21 Dec 23
Prospectus supplement
6:23pm
424B3
bh9wodei dna7f5xe2v
1 Dec 23
Prospectus supplement
4:33pm
S-4/A
4gbn1p44h
30 Nov 23
Registration of securities issued in business combination transactions (amended)
9:13pm
S-4
h1q3a w3p
13 Nov 23
Registration of securities issued in business combination transactions
9:35pm
425
93gu0w
4 Oct 23
Business combination disclosure
8:13am
8-K
falsf avtsg
4 Oct 23
Standard BioTools and SomaLogic to Combine in All-Stock Merger
8:08am
8-K
EX-3.7
w6owsu1 i7wx
5 Apr 22
Fluidigm Stockholders Approve $250 Million Strategic Capital Infusion
5:07pm
8-K
EX-3.6
3tmki1xr2el
5 Apr 22
Fluidigm Stockholders Approve $250 Million Strategic Capital Infusion
5:07pm
PRE 14A
9oxx8ke2
11 Feb 22
Preliminary proxy
9:31pm
DEFA14A
p4uuq
24 Jan 22
Additional proxy soliciting materials
5:27pm
8-K
pa90m3vrgrh1n1xe4jyv
24 Jan 22
Fluidigm Announces $250 Million Strategic Capital Infusion from
5:24pm